Repligen [RGEN] vs Avantor [AVTR] Detailed Stock Comparison
Repligen
NASDAQ
Loading...
Avantor
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Repligen wins in 4 metrics, Avantor wins in 15 metrics, with 0 ties. Avantor appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Repligen | Avantor | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 511.11 | 11.27 | Avantor |
| Price-to-Book Ratio | 3.31 | 1.23 | Avantor |
| Debt-to-Equity Ratio | 34.44 | 67.49 | Repligen |
| PEG Ratio | 65.76 | 10.07 | Avantor |
| EV/EBITDA | 55.78 | 10.84 | Avantor |
| Profit Margin (TTM) | -2.05% | 10.31% | Avantor |
| Operating Margin (TTM) | 6.36% | 7.63% | Avantor |
| EBITDA Margin (TTM) | 6.36% | 7.63% | Avantor |
| Return on Equity | -1.29% | 11.73% | Avantor |
| Return on Assets (TTM) | -0.90% | 3.24% | Avantor |
| Free Cash Flow (TTM) | $142.49M | $692.00M | Avantor |
| 1-Year Return | -32.13% | -54.44% | Repligen |
| Price-to-Sales Ratio (TTM) | 9.76 | 1.16 | Avantor |
| Enterprise Value | $6.67B | $11.55B | Avantor |
| EV/Revenue Ratio | 9.89 | 1.73 | Avantor |
| Gross Profit Margin (TTM) | 53.65% | 32.92% | Repligen |
| Revenue per Share (TTM) | $12 | $10 | Repligen |
| Earnings per Share (Diluted) | $-0.25 | $1.01 | Avantor |
| Beta (Stock Volatility) | 1.05 | 0.96 | Avantor |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Repligen vs Avantor Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Repligen | -1.89% | -3.03% | -8.77% | -10.53% | -27.25% | -20.64% |
| Avantor | 1.01% | -15.33% | -15.77% | -4.69% | -40.61% | -46.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Repligen | -32.13% | -55.40% | -22.09% | 222.31% | 3,307.29% | 3,296.97% |
| Avantor | -54.44% | -60.15% | -44.97% | -21.52% | -21.52% | -21.52% |
Performance & Financial Health Analysis: Repligen vs Avantor
| Metric | RGEN | AVTR |
|---|---|---|
| Market Information | ||
| Market Cap | $6.58B | $7.76B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,189,571 | 19,256,440 |
| 90 Day Avg. Volume | 868,660 | 13,953,210 |
| Last Close | $111.37 | $11.49 |
| 52 Week Range | $102.97 - $182.52 | $10.82 - $27.83 |
| % from 52W High | -38.98% | -58.70% |
| All-Time High | $327.32 (Sep 20, 2021) | $44.37 (Sep 20, 2021) |
| % from All-Time High | -65.98% | -74.10% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | -0.01% |
| Quarterly Earnings Growth | 1.60% | -0.30% |
| Financial Health | ||
| Profit Margin (TTM) | -0.02% | 0.10% |
| Operating Margin (TTM) | 0.06% | 0.08% |
| Return on Equity (TTM) | -0.01% | 0.12% |
| Debt to Equity (MRQ) | 34.44 | 67.49 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $35.34 | $9.22 |
| Cash per Share (MRQ) | $12.41 | $0.66 |
| Operating Cash Flow (TTM) | $164.14M | $681.80M |
| Levered Free Cash Flow (TTM) | $116.79M | $688.84M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Repligen vs Avantor
| Metric | RGEN | AVTR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 511.11 | 11.27 |
| Forward P/E | 65.76 | 10.07 |
| PEG Ratio | 65.76 | 10.07 |
| Price to Sales (TTM) | 9.76 | 1.16 |
| Price to Book (MRQ) | 3.31 | 1.23 |
| Market Capitalization | ||
| Market Capitalization | $6.58B | $7.76B |
| Enterprise Value | $6.67B | $11.55B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 9.89 | 1.73 |
| Enterprise to EBITDA | 55.78 | 10.84 |
| Risk & Other Metrics | ||
| Beta | 1.05 | 0.96 |
| Book Value per Share (MRQ) | $35.34 | $9.22 |
Financial Statements Comparison: Repligen vs Avantor
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RGEN | AVTR |
|---|---|---|
| Revenue/Sales | $169.17M | $1.58B |
| Cost of Goods Sold | $78.42M | $1.05B |
| Gross Profit | $90.76M | $534.90M |
| Research & Development | $12.92M | N/A |
| Operating Income (EBIT) | $6.58M | $147.40M |
| EBITDA | $29.07M | $230.80M |
| Pre-Tax Income | $7.94M | $85.70M |
| Income Tax | $2.11M | $21.20M |
| Net Income (Profit) | $5.83M | $64.50M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RGEN | AVTR |
|---|---|---|
| Cash & Equivalents | $697.23M | $315.70M |
| Total Current Assets | $1.03B | $2.28B |
| Total Current Liabilities | $152.00M | $2.03B |
| Long-Term Debt | $668.54M | $3.28B |
| Total Shareholders Equity | $1.99B | $6.10B |
| Retained Earnings | $413.18M | $2.27B |
| Property, Plant & Equipment | $265.24M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RGEN | AVTR |
|---|---|---|
| Operating Cash Flow | $14.16M | $86.60M |
| Capital Expenditures | $-3.52M | N/A |
| Free Cash Flow | $10.58M | $81.30M |
| Debt Repayment | N/A | $-31.30M |
| Common Stock Repurchase | N/A | $-4.90M |
Short Interest & Institutional Ownership Analysis
| Metric | RGEN | AVTR |
|---|---|---|
| Shares Short | 3.40M | 40.07M |
| Short Ratio | 4.65 | 3.41 |
| Short % of Float | 0.08% | 0.08% |
| Average Daily Volume (10 Day) | 1,189,571 | 19,256,440 |
| Average Daily Volume (90 Day) | 868,660 | 13,953,210 |
| Shares Outstanding | 56.09M | 680.80M |
| Float Shares | 52.57M | 664.21M |
| % Held by Insiders | 0.06% | 0.01% |
| % Held by Institutions | 1.05% | 1.00% |
Dividend Analysis & Yield Comparison: Repligen vs Avantor
| Metric | RGEN | AVTR |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |